The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  European Journal of Biochemistry

• Publication date

  1994-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1432-1033.1994.TB18748.XPMID 7909520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• J+ = J

  1994cited by this paper
• Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells.

  1992cited by this paper
• Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms.

  1991cited by this paper
• Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b.

  1991cited by this paper
• P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.

  1991cited by this paper
• In vitro and in vivo modulation of multi‐drug resistance with amiodarone

  1991cited by this paper
• Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient.

  1990cited by this paper
• The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.

  1990cited by this paper
• Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.

  1990cited by this paper
• Pharmacology of drugs that alter multidrug resistance in cancer.

  1990cited by this paper
• Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs.

  1990cited by this paper
• Multidrug resistance and its circumvention.

  1990cited by this paper
• Differential transport properties of two mdr gene products are distinguished by progesterone.

  1990cited by this paper
• The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.

  1990cited by this paper
• Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression.

  1989cited by this paper
• P-glycoprotein and multidrug resistance in cancer chemotherapy.

  1989cited by this paper
• Immunohistochemical detection of P‐glycoprotein in human tumor cells with a low degree of drug resistance

  1989cited by this paper
• Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.

  1989cited by this paper
• Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells.

  1989cited by this paper
• Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.

  1989cited by this paper
• Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

  1989cited by this paper
• Correlation of multidrug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells

  1989cited by this paper
• Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.

  1989cited by this paper
• Properties of verapamil-hypersensitive multidrug-resistant Chinese hamster ovary cells.

  1988cited by this paper
• Mechanism of multidrug resistance.

  1988cited by this paper
• Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.

  1988cited by this paper
• Multidrug resistance.

  1988cited by this paper
• Induction by verapamil of a rapid increase in ATP consumption in multidrug‐resistant tumor cells

  1988cited by this paper
• Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.

  1987cited by this paper
• Thermodynamics and Control of Biological Free-Energy Transduction

  1987cited by this paper
• Potentiation of doxorubicin cytotoxicity by the calcium antagonist bepridil in anthracycline-resistant and -sensitive cell lines. A comparison with verapamil.

  1987cited by this paper
• Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation.

  1987cited by this paper
• Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells.

  1986cited by this paper
• Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling.

  1986cited by this paper
• Cooperativity Theory in Biochemistry

  1985cited by this paper
• Reversal of adriamycin resistance by verapamil in human ovarian cancer.

  1984cited by this paper
• Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.

  1983cited by this paper
• A flow-through tissue culture system with fast dynamic response.

  1982cited by this paper
• Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

  1982cited by this paper
• Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

  1981cited by this paper
• Intramitochondrial and extramitochondrial concentrations of adenine nucleotides and inorganic phosphate in isolated hepatocytes from fasted rats.

  1978cited by this paper
• Relationship between oxygen uptake of perifused rat-liver cells and the cytosolic phosphorylation state calculated from indicator metabolites and a redetermined equilibrium constant.

  1978cited by this paper
• Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.

  1978cited by this paper

• Enhanced in-vitro bioavailability of curcumin, lutein and isoflavones through interaction with spearmint (Mentha spicata) via its bioactive component (R)-(-)-carvone.

  2025cites this paper
• The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.

  2022cites this paper
• 2-Cl-IB-MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines

  2022cites this paper
• Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance

  2020cites this paper
• Location of contact residues in pharmacologically distinct drug binding sites on P‐glycoprotein

  2017cites this paper
• Structures of multidrug and toxic compound extrusion transporters and their mechanistic implications

  2015cites this paper
• Evidence against a role of P-glycoprotein in the clearance of the Alzheimer’s disease Aβ1–42 peptides

  2015cites this paper
• Identification of trichlormethiazide as a Mdr1a/b gene expression enhancer via a dual secretion-based promoter assay

  2015cites this paper
• Structural basis for the blockade of MATE multidrug efflux pumps

  2015cites this paper
• Comment on “Sweat but no gain”: Inhibiting proliferation of multidrug resistant cancer cells with “Ersatzdroges”

  2015cites this paper
• The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1

  2015cites this paper
• Multiple Drug Transport Pathways through Human P-Glycoprotein.

  2015cites this paper
• A reciprocating twin-channel model for ABC transporters

  2014cites this paper
• Co(II) and Cu(II) pyrophosphate complexes have selectivity and potency against Mycobacteria including Mycobacterium tuberculosis.

  2013cites this paper
• Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells

  2012cites this paper
• On-line identification of P-glycoprotein substrates by monitoring of extracellular acidification and respiration rates in living cells.

  2011cites this paper
• Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.

  2011cites this paper
• Molecular Dissection of Dual Pseudosymmetric Solute Translocation Pathways in Human P-Glycoprotein

  2011cites this paper
• A Novel MDR1 GT1292-3TG (Cys431Leu) Genetic Variation and Its Effect on P-glycoprotein Biologic Functions

  2010cites this paper
• P-glycoprotein and membrane permeability as determinants of xenobiotic bioavailability and bioaccumulation

  2007cites this paper
• Pharmacological strategies for overcoming multidrug resistance.

  2006cites this paper
• P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.

  2006cites this paper
• What do proton motive force driven multidrug resistance transporters have in common?

  2005cites this paper
• Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.

  2005cites this paper
• Regional difference in P-glycoprotein function in rat intestine.

  2005cites this paper
• Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability

  2005cites this paper
• Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs.

  2005cites this paper
• Drug efflux mechanism by a secondary transporter LmrP of Lactococcus lactis

  2004cites this paper
• 2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance

  2004cites this paper
• Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.

  2004cites this paper
• Allosteric Modulation of Human P-glycoprotein

  2003cites this paper
• Cytosolic beta-glycosidases for activation of glycoside prodrugs of daunorubicin.

  2003cites this paper
• N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells.

  2003cites this paper
• Evidence for the locations of distinct steroid and Vinca alkaloid interaction domains within the murine mdr1b P-glycoprotein.

  2002cites this paper
• Effect of mdr1a P-Glycoprotein Gene Disruption, Gender, and Substrate Concentration on Brain Uptake of Selected Compounds

  2001cites this paper
• Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes.

  2001cites this paper
• Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase.

  2001cites this paper
• Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence.

  2000cites this paper
• Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: evidence for half-of-the-sites reactivity.

  2000cites this paper
• Association of tamoxifen biliary excretion rate with prior tamoxifen exposure and increased mdr1b expression.

  2000cites this paper
• Everted rat intestinal sacs: a new model for the quantitation of P-glycoprotein mediated-efflux of anticancer agents.

  2000cites this paper
• Heat shock treated oesophageal cancer cells become thermosensitized against anticancer drugs.

  2000cites this paper
• Konings Transporters Molecular Properties of Bacterial Multidrug

  2000influential citation
• Multidrug resistance P-glycoprotein is not involved in cholesterol esterification.

  2000cites this paper
• Relating multidrug resistance phenotypes to the kinetic properties of their drug-efflux pumps.

  2000cites this paper
• Molecular Properties of Bacterial Multidrug Transporters

  2000influential citation
• The Oral Route for the Administration of Cytotoxic Drugs: Strategies to Increase the Efficiency and Consistency of Drug Delivery

  2000cites this paper
• Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.

  2000cites this paper
• Molecular characterization and antibiotic specificities of multidrug transporters in Lactoccus lactis

  2000cites this paper
• The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein

  1999cites this paper
• The secondary multidrug transporter LmrP contains multiple drug interaction sites.

  1999cites this paper
• Applications of liposome technology in modulating p-glycoprotein mediated multidrug resistance

  1999cites this paper
• Lack of competition of substrates for P-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1.

  1999cites this paper
• The mechanism of ATP-dependent multidrug transport by P-glycoprotein.

  1998cites this paper
• A method for studying plasma membrane transport with intact cells using computerized fluorometry.

  1998cites this paper
• Interactions between P‐glycoprotein substrates and other cationic drugs at the hepatic excretory level

  1998cites this paper
• Changes of the membrane potential profile induced by verapamil and propranolol.

  1998cites this paper
• Identification of drug interaction sites in P-glycoprotein.

  1998cites this paper
• The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.

  1998cites this paper
• Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.

  1998cites this paper
• Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity.

  1997cites this paper
• ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines.

  1997cites this paper
• Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.

  1997cites this paper
• Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.

  1997cites this paper
• Mutually co-operative interactions between modulators of P-glycoprotein.

  1997cites this paper
• The multi‐drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P‐glycoprotein by an allosteric interaction

  1997cites this paper
• Phosphorylation Site Mutations in the Human Multidrug Transporter Modulate Its Drug-stimulated ATPase Activity*

  1997cites this paper
• Kinetics of the multidrug transporter (P-glycoprotein) and its reversal.

  1997cites this paper
• Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.

  1996cites this paper
• Evidence for P‐glycoprotein‐modulated penetration of morphine‐6‐glucuronide into brain capillary endothelium

  1996cites this paper
• Reversal of multidrug resistance by valinomycin is overcome by CCCP.

  1996cites this paper
• Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.

  1996cites this paper
• Chemotherapeutic drug cytotoxicity enhancement in human cells in culture

  1996cites this paper
• Energy, control and DNA structure in the living cell.

  1995cites this paper
• Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.

  1995cites this paper
• Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

  1995cites this paper
• Serotonin uptake and its modulation in rat jejunal enterocyte preparation.

  1995cites this paper
• Verapamil competes with doxorubicin for binding to anionic phospholipids resulting in increased internal concentrations and rates of passive transport of doxorubicin.

  1995cites this paper
• Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?

  1995cites this paper
• Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.

  1995cites this paper
• The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.

  1995cites this paper
• Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells.

  1994cites this paper